Does Gut Microbial Methylglyoxal Metabolism Impact Human Physiology?
Methylglyoxal (MGO) is a highly reactive dicarbonyl associated with oxidative stress, inflammation, and chronic diseases, particularly diabetic vascular complications and atherosclerosis through the formation of advanced glycation end products (AGEs). In the setting of human/host diseases, the forma...
Saved in:
Main Authors: | Oluwatomisono I. Akinrimisi, Kim Maasen, Jean L. J. M. Scheijen, Ina Nemet, Max Nieuwdorp, Casper G. Schalkwijk, Nordin M. J. Hanssen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/14/7/763 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The inhibition of TXNRD1 by methylglyoxal impairs the intracellular control of Mycobacterium tuberculosis
by: Hanxiong Li, et al.
Published: (2025-09-01) -
Meloxicam mitigated methylglyoxal-induced glycative stress in rats
by: Talha Fayyaz, et al.
Published: (2025-05-01) -
Receptor-like kinase OsASLRK regulates methylglyoxal response and content in rice
by: LIN Fa-ming, et al.
Published: (2021-07-01) -
Methylglyoxal-induced RNA modifications decrease RNA stability and translation and are associated with type 2 diabetes
by: Edwin De Jesus Lopez Gonzalez, et al.
Published: (2025-08-01) -
Free Methylglyoxal and Lactate Produced and Released by Cultured Cancer and Non-Cancer Cells: Implications for Tumor Growth and Development
by: Dominique Belpomme, et al.
Published: (2025-06-01)